Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
12-14 August, 2025
Not Confirmed
Not Confirmed
17-21 August, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
12-14 August, 2025
Industry Trade Show
Not Confirmed
17-21 August, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
31 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/31/3124855/29446/en/BioCryst-Announces-Charlie-Gayer-to-Succeed-Jon-Stonehouse-as-Chief-Executive-Officer-Upon-his-Retirement-in-December.html
21 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/21/3118589/29446/en/BioCryst-to-Report-Second-Quarter-2025-Financial-Results-on-August-4.html
09 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/09/3112438/29446/en/BioCryst-to-Highlight-Patient-focused-Research-at-the-2025-US-HAEA-National-Summit.html
07 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/07/3110894/29446/en/BioCryst-Appoints-Babar-Ghias-Chief-Financial-Officer-and-Head-of-Corporate-Development.html
03 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/03/3109787/29446/en/BioCryst-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
27 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/27/3106473/29446/en/BioCryst-Announces-Sale-of-European-ORLADEYO-berotralstat-Business-to-Neopharmed-Gentili-for-up-to-264-Million.html
ABOUT THIS PAGE
BioCryst Pharmaceuticals is a supplier offers 2 products (APIs, Excipients or Intermediates).
Find a price of Peramivir bulk offered by BioCryst Pharmaceuticals
Find a price of Ulodesine Hydrochloride bulk offered by BioCryst Pharmaceuticals